U.S. FDA approves Lexicon Pharma’s drug for heart failure
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug for a broad […]
Oil prices rise as US closes in on debt deal
By Arathy Somasekhar HOUSTON (Reuters) -Oil prices ticked up on Friday as U.S. officials appeared close to striking a debt-ceiling
Wall Street rallies, European shares see biggest gain in 2 months
By Chris Prentice and Huw Jones NEW YORK/LONDON (Reuters) -Wall Street’s main indexes rose and European shares logged their largest
Elon Musk’s Neuralink wins FDA approval for human study of brain implants
By Rachael Levy, Marisa Taylor and Akriti Sharma (Reuters) -Elon Musk’s Neuralink received U.S. Food and Drug Administration (FDA) clearance
Israeli settler kills Palestinian who army says attempted stabbing, amid rise in violence
By Ali Sawafta AL-MUGHAYYIR, West Bank (Reuters) -An Israeli settler shot dead a Palestinian man who the military said tried
Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines
By Blake Brittain (Reuters) – Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna
Twitter not paying PR firm’s bills after Musk buyout -lawsuit
By Jonathan Stempel (Reuters) – A former public relations firm for Twitter sued the social media company on Friday, saying
Two more Oath Keepers sentenced to prison over US Capitol attack
By Jacqueline Thomsen WASHINGTON (Reuters) -Two members of the far-right Oath Keepers were sentenced to prison on Friday for their
Factbox-Top US credit rating under watch as debt ceiling talks drag on
(Reuters) – Drawn-out negotiations between the White House and Republicans to raise the $31.4 trillion debt ceiling have unnerved markets
Ukraine says Russia plans to simulate accident at nuclear power plant
(Reuters) – Ukraine’s defence ministry on Friday said Russia was planning to simulate a major accident at a nuclear power